Anthony Sebba, ACR 2020 – Pain in Patients with Rheumatoid Arthritis (Part 2)
We caught up with Anthony Sebba (Arthritis Associates, FL, USA) to talk about the results from his study analysing pain and other patient-reported outcomes in patients with rheumatoid arthritis. The abstract ‘Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials.’ (ABSTRACT NUMBER: 1237) was presented at the virtual ACR Convergence 2020, 5-9 November 2020.
Questions
- Could you tell us a little about the study and its findings? (0:06)
Disclosures: Consultant or speaker for Genentech, Sanofi, Lilly, Gilead and Amgen.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ACR 2020 Annual Meeting (Virtual).